StonvexLoading…
StonvexStonvexStonvexCore line items from ZTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.47B | $9.26B | $8.54B | $8.08B |
Operating Income | $3.36B | $3.13B | $2.94B | $2.66B |
Net Income | $2.67B | $2.49B | $2.34B | $2.11B |
EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 |
Total Assets | $15.47B | $14.24B | $14.29B | $14.93B |
Total Liabilities | $12.14B | $9.47B | $9.29B | $10.52B |
Cash & Equivalents | $2.31B | $1.99B | $2.04B | $3.58B |
Free Cash Flow OCF − CapEx | $2.28B | $2.30B | $1.62B | $1.33B |
Shares Outstanding | 424.93M | 448.47M | 458.37M | 463.81M |